Short Interest in LENSAR, Inc. (NASDAQ:LNSR) Drops By 16.6%

LENSAR, Inc. (NASDAQ:LNSR) saw a large decline in short interest during the month of August. As of August 15th, there was short interest totalling 59,600 shares, a decline of 16.6% from the July 31st total of 71,500 shares. Currently, 0.7% of the company’s stock are short sold. Based on an average daily trading volume, of 24,000 shares, the short-interest ratio is currently 2.5 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in LENSAR stock. Brandes Investment Partners LP grew its position in shares of LENSAR, Inc. (NASDAQ:LNSR) by 3.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 226,676 shares of the company’s stock after purchasing an additional 6,827 shares during the quarter. Brandes Investment Partners LP owned approximately 2.01% of LENSAR worth $796,000 as of its most recent filing with the SEC. 40.15% of the stock is currently owned by hedge funds and other institutional investors.

LENSAR Stock Performance

NASDAQ:LNSR opened at $4.67 on Monday. LENSAR has a 1 year low of $1.80 and a 1 year high of $5.60. The stock has a market cap of $54.22 million, a P/E ratio of -2.96 and a beta of 0.65. The stock has a 50-day simple moving average of $4.63 and a 200-day simple moving average of $4.20.

LENSAR (NASDAQ:LNSR) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.53) earnings per share (EPS) for the quarter. The business had revenue of $12.64 million during the quarter. LENSAR had a negative net margin of 27.83% and a negative return on equity of 30.69%.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.